PetVivo Holdings (NASDAQ: PETV, PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets, announced its approval to dual list its shares on Upstream, a MERJ Exchange market and global securities trading app. According to the announcement, effective beginning at 10:00 a.m. ET on March 5, 2024, PetVivo to commence trading on Upstream under the ticker symbol PETV. The dual listing is designed to provide PetVivo the opportunity to access a global, digital-first investor base outside the U.S. that can trade using credit, debit, PayPal, USD, or USDC; unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in PetVivo.
To view the full press release, visit https://ibn.fm/zk0Cp
About PetVivo Holdings Inc.
PetVivo Holdings is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The company’s strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics. PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of 21 patents protects the company’s biomaterials, products, production processes and methods of use. The company’s lead product SPRYNG(TM) with OsteoCushion(TM) technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats dogs and horses, is currently available for commercial sale. For more information about PetVivo and its revolutionary product, Spryng with OsteoCushion Technology, please contact [email protected] or visit www.PetVivo.com or www.SpryngHealth.com.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN